Healx
AI-powered drug repurposing for rare diseases
Healx uses AI to discover new treatments for rare diseases by repurposing existing drugs. The company's Healnet platform combines knowledge graphs, network pharmacology, and machine learning to identify novel drug-disease connections across hundreds of rare diseases. By focusing on drugs with established safety profiles, Healx aims to dramatically reduce the time and cost of bringing treatments to underserved patient populations.
Target Discovery, Virtual Screening, Platform
Healnet
500+ rare diseases analyzed
Technology
Healnet AI platform integrates biomedical knowledge graphs, network pharmacology, and machine learning to identify drug repurposing opportunities for rare diseases. The platform has analyzed over 500 rare diseases to find novel therapeutic connections using existing approved or clinical-stage drugs.
Leadership
Tim Guilliams
CEO & Co-Founder
PhD from University of Cambridge
Similar companies
BenevolentAI
AI-enabled knowledge graph for drug discovery and repurposing
clinical · 2014Valo Health
Integrating human data and computation for end-to-end drug development
clinical · 2019Bioptimus
Universal biology foundation model from ex-DeepMind team
platform · 2024Calico Life Sciences
Alphabet-backed research into the biology of aging
clinical · 2013Get updates on Healx
We'll notify you when we publish updates about Healx.